LOTUSEYE112.50

Lotus Eye Hospital and Institute Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹234 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
LOTUSEYE
FY26
GPTHEALTH
FY26
GKSL
FY26
SHALBY
FY26
Peer
Median
Valuation — at last close
P/E2812.50×31.27×69.84×44.97×44.97× +6154%
P/B3.89×4.90×5.38×1.55×4.90× -21%
EV/EBITDA72.00×15.33×50.98×14.13×15.33× +370%
Market Cap₹234 Cr₹1,322 Cr₹1,371 Cr₹1,562 Cr₹1,371 Cr -83%
Growth
Revenue CAGR 3Y4.52%12.35%12.35% -63%
Revenue CAGR 5Y10.66%
Net Income CAGR 3Y-72.98%-19.97%-19.97% -265%
Revenue YoY (latest Q)26.19%17.83%11.74%14.79% +77%
Net Income YoY (latest Q)12.65%65.73%36.70%51.22% -75%
Profitability
EBITDA Margin6.30%17.81%32.85%12.51%17.81% -65%
Net Income Margin0.15%8.93%20.50%3.04%8.93% -98%
Return on Common Equity0.13%15.67%6.08%3.72%6.08% -98%
Return on Capital Employed-0.50%14.82%8.24%5.76%8.24% -106%
Return on Assets0.10%9.08%5.65%1.89%5.65% -98%
Credit & Quality
Total Debt/Equity0.19×0.06×0.06×0.54×0.06× +217%
Interest Coverage-0.43×6.93×11.84×1.87×6.93× -106%
Scale — latest FY
Revenue / Total Income₹53.7 Cr₹473 Cr₹82 Cr₹1,141 Cr₹473 Cr -89%
Net Income₹0.1 Cr₹42.2 Cr₹16.8 Cr₹34.7 Cr₹34.7 Cr -100%
Total Assets₹82.6 Cr₹465 Cr₹298 Cr₹1,839 Cr₹465 Cr -82%
EPS₹0.04₹5.15₹2.49₹3.23₹3.23 -99%
Book Value per Share₹28.92₹32.84₹32.31₹93.54₹32.84 -12%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.